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Al~traet 
The lamin B receptor (p58) is an inner nuclear membrane protein that forms an in vivo complex with the nuclear lamins, a nuclear envelope kinase, 
and two other nuclear proteins with apparent Mr of 18,000 (p18) and 34,000 (p34). We now report the isolation of p34 by partial dissociation of 
the immunoaffinity-purified p58protein complex. Determination of the N-terminal amino acid sequence of purified p34 shows that this polypeptide 
is homologous to p32, a splicing factor 2 (SF2)-associated protein. The relatedness between p34 and p32 can be further established by showing that 
antibodies raised against N- and C-terminal peptides of p32 cross-react with purified p34. As the amino acid sequence of p58 contains an 
arginine/serine (RS)-rich region similar to the RS-rich region found in SF 2, we speculate that these domains provide binding sites for p34 and that 
this protein may be a linker between the nuclear membrane and intranuclear spliceosomal substructures. 
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1. Introduction 2. Materials and methods 
Higher eukaryotic cells possess afibrous lamina which 
lines the inner nuclear membrane. The nuclear lamina is 
tethered to the inner nuclear membrane through several 
integral membrane proteins [1,2]. One such protein is the 
polypeptide p58, also known as the lamin B receptor [1]. 
p58 posseses a long N-terminal domain, which is nucleo- 
plasmically disposed, and eight predicted membrane- 
spanning segments [3]. 
p58 binds in vitro to nuclear lamin B with an affinity 
of ~200 nM and in a phosphosphorylation-dependent 
manner [1,4]. Furthermore, recent work has shown that 
p58 forms during interphase a multimeric complex which 
includes the nuclear lamins A and B, a specific p58 kinase 
and two other polypeptides with molecular masses of 18 
kDa and 34 kDa [5]. The identity of the non-lamin part- 
ners of p58 remains unknown; however, it is likely that 
these proteins regulate the p58-1amin interactions and 
affect the aggregation state of p58. Another potential 
function of the p58-associated proteins may be the regu- 
lation of interactions between p58 and DNA or other 
intranuclear structures. The N-terminal domain of p58 
possesses three DNA-binding motifs and a report has 
appeared claiming specific binding to DNA in vitro [6]. 
Prompted by these findings, we decided to characterize 
the 34 kDa protein found in the p58 complex. Results 
presented below show that this protein (p34) is homolo- 
gous to p32, a previously identified protein associated 
with splicing factor 2. 
*Corresponding author. Fax: (49) (6221) 387 306. 
2.1. Peptides and antibodies 
Peptides p34-N (CGGDFLSDEIKEERK) and p34-C (CGGTGE- 
SEWKDTNYTLNTDS), corresponding toN-terminal residues 11-22 
and to the C-terminal residues 141-157 of HeLa p32 [7], were made in 
the Protein Sequencing and Peptide Synthesis Facility of EMBL (Hei- 
delberg, Germany). The tripeptide CGG was added to the sequences 
for coupling purposes. For immunization, the synthetic peptides were 
coupled to keyhole limpet hemocyanin (Sigma) using m-maleimidoben- 
zoyl-N-hydroxysuccinimide ester (MBS) as a cross-hnker [8]. The im- 
munization procedure was as previously described [5]. To purify the 
anti-peptide antibodies from whole sera, an affinity matrix was pre- 
pared by coupling the two peptides to Epoxy-activated Sepharose 6B 
(Sigma) [9]. The antisera were passed through the affinity column and 
the bound antibodies were eluted by washing the column with 0.2 M 
glycine-HCl, pH 2.3, and 0.5 M NaCI. The collected fractions were 
neutralized by the addition of 1 M Tris-HCl, pH 8, pooled and dialysed 
against PBS. The anti-p58 antibodies ~tR 1 and ctR6 were raised against 
peptides R1 (KQRKSQSSSSSPSRRSR SRS) and R6 (KPSENNTYN- 
GEPDSTERND) corresponding to residues 61-80 and 119-139 of 
chicken liver p58 [3], respectively. The preparation and affinity purifica- 
tion of these antibodies has been described previously [5,10]. Both 
antibodies were previously shown to be specific for avian p58 [5,10]. For 
construction of the preparatory immunoaffinity column, 1 mg of affin- 
ity purified ~RI IgG was bound to 0.5 ml of protein A-Sepharose 
(PAS) and the antibodies were covalently coupled to protein A using 
dimethylpimelimidate (DMP) as a cross-linker [8]. 
2.2. Purification of p34 from turkey erythrocytes 
Turkey erythrocyte ghosts were prepared from 80 ml of turkey blood 
by hypotonic lysis in 5 mM Na3PO4, 2 mM MgC12, 1 mM DTT and 1.3 
mM PMSF, pH 7.4, and extracted with 300 ml 1% Triton buffer (1% 
Triton X-100, 50 mM Tris-HC1, pH 7.4, 150 mM NaCI) containing 
protease inhibitors (1/~g/ml leupeptin, 1/~g/ml pepstatin, 5/lg/ml aprot- 
inin and 1 mM PMSF) for 30 min on ice. After centrifugation at 
12,000 x g for 15 min, the detergent-soluble extract was applied to the 
immunoaffinity column and recycled three times. The column was 
subsequently washed with 1% Triton buffer and then with 0.1% Triton 
buffer. Weakly bound proteins were eluted by applying a solution of 
0.5 M NaC1 in 0.1% Triton buffer. Finally, the column was treated 
either with a solution of the R! peptide (2 mg/ml in 0.1% Triton buffer) 
(to elute the lamin B receptor and associated proteins including p34) 
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or with 1 M NaCI in the same buffer (to release and elute only p34). 
p34 was further purified by passing the 1 M NaCI eluate of the immu- 
noaffmity column through a Sephacryl S-100 gel-filtration column 
equilibrated in 0.01% Triton X-100, 20 mM Tris-HC1, pH 7.6, 50 mM 
Nacl. Fractions containing p34 were pooled and concentrated by ul- 
trafiltration. 
2.3. Microsequencing 
Purified p34 was concentrated by TCA precipitation, resolved in a 
SDS-PAGE gel, transferred to a ProBlott membrane (Applied Biosys- 
tems) and stained by Coomassie blue. The band at 34 kDa was excised 
from the blot and used for microsequencing. Protein sequence was 
dtermined by Edman degradation employing the Applied Biosystems, 
Model 477A, system. 
2.4. Other methods 
HeLa cells were frac~ionated into post-nuclear supernatant (PNS), 
nuclear extract (NE) and nuclear pellet (hiP) essentially as described by 
Krainer et al. [11]. SDS-PAGE was performed according to Laemmli 
[12]. Immunoblotting was performed as previously described using 
[125I]protein A for the detection of the primary antibodies [13]. The 
FASTA programme was used for data bank searches [14]. 
3. R ~  
To isolate p58 and associated proteins, a Triton X-100 
extract of turkey erythrocyte ghosts was applied to an 
immunoaffinity column containing anti-peptide, anti- 
p58 antibodies (ctR1; for details see section 2). Elution 
of the immunoaffinity column with 2 mg/ml of the R 1 
peptide yielded p58 and associated proteins, including 
p34 (Fig. 1, lane 1). To purify p34 away from other 
components, we took advantage of the fact that this 
protein remains associated with the p58 complex in 0.5 
M salt, but dissociates from it in 1 M salt [5]. Therefore, 
we repeated the previous experiment and, before elution 
with R1, we applied to the column a buffer containing 
1 M NaCI/0.1% Triton X-100. SDS-PAGE analysis and 
silver staining showed that the 1 M salt eluate was highly 
enriched in p34 (Fig. 1, lane 2). To examine whether any 
of the p34 protein remained bound to the column, the R1 
peptide was applied after the salt elution and the peptide 
eluate was analyzed by SDS-PAGE. As shown in Fig. 1, 
lane 3, the R1 eluate contained all of the known compo- 
nents of the p58 complex, except p34. From these exper- 
iments we concluded that p34 could be quantitatively 
recovered by washing the immunoaffinity matrix with 1 
M NaC1. 
Fractions enriched in p34, after an additional purifica- 
tion step through a Sephacryl S100 column (not shown), 
were electrophoresed and blotted onto PVDF mem- 
branes. To obtain protein sequencing information, the 
band at 34 kDa was excised and subjected to Edman 
degradation. Fig. 2A shows the sequence of the first 20 
N-terminal residues of turkey erythrocyte p34 (16 amino 
acids certain, 3 amino acids unidentified and 1 amino 
acid uncertain). A search in the GenEMBL databank 
revealed that the deduced N-terminal sequence is highly 
homologous to the N-terminal sequence of p32, a splic- 
ing factor 2 (SF2)-associated protein, originally charac- 
terized in HeLa cells [7]. The two proteins how 12 iden- 
tities, 3 conservative substitutions and one probable 
match in a stretch of 20 residues (Fig. 2A). No other 
proteins were found with significant homology to the p34 
N-terminus. 
To confirm these results, we have taken an immuno- 
chemical approach. Two peptides corresponding to the 
N-terminal residues 11-22 and to the C-terminal residues 
141-157 of HeLa p32 were synthesized, coupled to KLH, 
and used as immunogens toraise specific antibodies. The 
resultant antisera (anti-N and anti-C, respectively) were 
affinity-purified and tested by Western blotting on HeLa 
cell subcellular fractions. Consistent with previous re- 
suits [7], the anti-N and anti-C antibodies recognized a
32 kDa protein present in HeLa nuclear extracts (Fig. 3, 
lanes 2). Some p32 was also present in the post-nuclear 
supernantant and the residue obtained after salt extrac- 
tion of HeLa cell nuclei (Fig. 3, lanes 1 and 3). Testing 
of subcellular fractions of turkey erythrocytes by the 
same method id not yield a detectable signal, probably 
because p34 represented a low abudance protein. How- 
ever, both anti-p32 antibodies readily recognized turkey 
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Fig. 1. Partial purification of p34 from turkey erythrocytes. SDS-PAGE 
analysis and silver staining of material eluted from the anti-R1 immu- 
noaffinity column with the antigenic peptide (lane 1), material eluted 
with 1 M NaC1 before applying the peptide (lane 2), and proteins eluted 
by the peptide after previous alt elution (lane 3). Pep. El., peptide 
eluate; 1 M NaC1 El., 1 M NaC1 eluate. The bands corresponding to
lamins A and B, p58, p34 and p18 are indicated by bars (from top to 
bottom). Dots point to proteins that specifically co-isolate with p58. 
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p34 : H2N-LXTEGXKAFAQFLTDEIXEE-  • • 
IIII III IIi=II II 
p32 : H2N-LHTDGDKAFVDFLSDEIKEE. . .  
(HeLa) 1 20 
B 
71 i01 
p58 : . . SPSRRSRSRSRSRSPGRPAKGRRRSSSHSRE. .  
202 
SF2 : . . YGRSRSRSRSRSRSRSRSNSRSRSYSPRRSR 
248 
GS PRYS PRHSRSRSRT. .  
Fig. 2. (A) Comparison between the N-terminal amino acid sequence 
of turkey erythrocyt¢ p34, as deduced by protein sequencing, and the 
N-terminal amino acid sequence of HeLA p32 [7]. Solid lines indicate 
identities and dashed lines indicate conservative substitutions. (B) Part 
of the amino acid sequence of p58 [3] and an analogous sequence inSF2 
[7], showing the existence of RS-rich regions in the two proteins. 
(Fig. 3, lanes 4). This suggests that p34 and p32 are 
antigenically related and contain common epitopes pres- 
ent at both the N- and the C-terminal parts of the two 
molecules. 
4. Discussion 
The lamin B receptor (p58) has been localized in the 
inner nuclear membrane [15] and shown to associate with 
the nuclear lamins A and B, a protein kinase that modi- 
fies p58 and a set of other polypeptides [5]. One of the 
latter proteins, p34 can be released from the p58 complex 
by high salt and does not co-isolate with p58 when ex- 
traction and purification are performed under conditions 
that favor phosphorylation (in the presence of ATP and 
phosphatase inhibitors) [5]. In this report we have de- 
scribed the partial purification of turkey erythrocyte p34 
and demonstrated that it is homologous to the HeLa 
protein p32 [7]. The possibility that p34 is co-isolated 
with p58 because it is directly recognized by the ~R1 
antibody can be safely ruled out since the same results 
have been obtained using another anti-p58 antibody, 
~R6 (data not shown). Unfortunately, our anti-p32 anti- 
bodies do not seem to recognize the native form of p32 
as they give no signal in indirect immunofluoresence 
assays. 
The human homologue of p34, i.e. the p32 protein, 
was initially identified as an element co-purifying with 
SF2, a well-characterized splicing factor [7]. It has been 
suggested that p32 is synthesized as a longer polypeptide 
containing 282 amino acids that is post-translationally 
227 
processed by removal of the initial 73 residues to a ma- 
ture protein of 209 amino acids [16]. The actual molecu- 
lar weight of mature p32, as deduced from its cDNA, is 
23.8 kDa and its calculated pI is -4.0 [7]. Bacterially 
expressed p32 does not have a splicing activity itself and 
does not affect he splicing activity of SF2 [7]. However, 
the fact that p32 and SF2 co-purify through several chro- 
matographic steps uggests a specific interaction between 
the two proteins [7]. 
Our anti-p58 antibodies do not react with the mam- 
malian form of p58 and thus we were unable to examine 
whether p32 is also associated with p58 in HeLa cells. 
At first glance, the presence of a p32 homologue in the 
lamin B receptor complex seems puzzling. However, 
closer inspection of the p58 and the SF2 sequences re- 
veals certain common characteristics. First, as previ- 
ously reported, SF2 and the N-terminal domain of p58 
are highly charged and contain numerous basic amino 
acids [3,7]. Furthermore, we have noticed that p58 con- 
tains in its N-terminal domain an arginine/serine (RS)- 
rich region, a motif also found near the C-terminus of 
SF2 (Fig. 2B). RS domains have also been identified in 
other essential splicing factors such as the family of SR 
proteins (which comprises SF2, SC35, SRp20, SRp55 
and SRp75) and U2AF, in Drosophila splicing regula- 
tors, in the integral U1 snPNP protein U1-70K [17,18], 
and in a 54 kDa nuclear protein of unknown function 
which, however, co-localizes with spliceosome compo- 
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Fig. 3. HeLa cell subcellular f actions (lanes 1-3) and partially purified 
turkey erythrocyte p34 (1 M salt eluate of the ~Rl immunoaffinity 
column; lanes 4) were analyzed by SDS-PAGE and either stained with 
Coomassie blue (A), or blotted and immunostained with affinity-puri- 
fied antibodies raised against he N-terminal (B) or C-terminal (C) 
peptide of HeLa p32. Lanes l, post-nuclear supernatant (PNS); lanes 
2, nuclear extract (NE); lanes 3, nuclear pellet (NP). Bars on the left 
correspond to molecular mass (in kDa). The positions of p34 and p32 
are indicated. 
228 G. Simons, S.D. Georgatos l FEBS Letters 346 (1994) 225-228 
nents [19]. It has been suggested that the RS domains are 
responsible for targeting proteins to the speckled subnu- 
clear compartments implicated in splicing [20]. More re- 
cently, it has been shown that the RS domains mediate 
protein-protein teractions between components of the 
splicing machinery [21,22], probably in a phosphoryla- 
tion-dependent manner [23]. The presence of a RS do- 
main in the lamin B receptor, amembrane protein of the 
nuclear envelope with no obvious involvement in RNA 
processing, suggests a wider role for this motif. Taking 
into account the acidic nature of p32/p34 and their asso- 
ciation with the lamin B receptor and SF2, one could 
speculate that the p32/p34 function as RS binding pro- 
teins. An alternative xplanation for the presence of a 
splicing factor-associated protein in the lamin B receptor 
complex is provided by previous immunoelectron mi- 
croscopy data which demonstrated that the nuclear 
speckled substructures that contain spliceosomal compo- 
nents extend to, and come into contact with, the nuclear 
envelope [24]. Furthermore, upon in vitro-induced differ- 
entiation of murine erythroleukemia (MEL) cells and 
before loss of the nucleus, splicing snRNPs migrate to 
the nuclear periphery, associate with the nuclear enve- 
lope and form a membrane-enclosed domain (SCIM, 
SnRNP Clusters Inside ,a Membrane domain) [25]. p32/ 
p34 may therefore function as a linking component be- 
tween the nuclear membrane and intranuclear stuctures 
involved in RNA splicing. 
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